Pharma & Biotech

After nearly a century as a publicly traded company, Walgreens Boots Alliance has concluded its stock market journey. The landmark...

The pharmaceutical industry faces a fundamental challenge: balancing medical innovation with affordable access to treatments. Gilead Sciences finds itself at...

Eli Lilly & Company is experiencing a remarkable upward trajectory that has captivated market participants. The pharmaceutical giant's equity has...

Shares of Nektar Therapeutics surged to unprecedented heights this week, reaching a new 52-week peak of $61.24 before settling at...

Cellectar Biosciences is attracting significant market attention following the release of encouraging interim data from its CLOVER-2 Phase 1b study....

Ocugen is executing a strategic campaign to position itself at the forefront of gene therapy. The company has announced a...

DexCom, the continuous glucose monitoring specialist, finds itself navigating turbulent market conditions as conflicting signals emerge about the company's near-term...

Amphastar Pharmaceuticals finds itself at a puzzling crossroads as conflicting market signals create uncertainty for investors. While fundamental valuation metrics...

Viking Therapeutics shares delivered a contradictory performance on Tuesday, advancing 1.86 percent to reach $27.88 and outpacing the S&P 500's...

Bayer's stock faces a pivotal moment as Germany's DAX-listed pharmaceutical and agricultural giant tests the psychologically significant €30 price level....